quarter

Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025

September 25, 2025 16:30 ET  | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) --…

5 months ago

Verano to Report Third Quarter 2025 Financial Results on October 29, 2025

CHICAGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a…

5 months ago

Cango Inc. Reports Second Quarter 2025 Unaudited Financial Results

HONG KONG, Sept. 4, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) today announced its unaudited financial results for the second quarter…

6 months ago

IBEX Limited to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on September 11, 2025

August 28, 2025 16:30 ET  | Source: Ibex Limited WASHINGTON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- IBEX Limited (“ibex”) (Nasdaq:…

6 months ago

NowVertical Group Reports Second Quarter 2025 Financial Results

TORONTO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSX-V: NOW) (“NOW” or the “Company”), a leader in AI-driven…

6 months ago

Crown Point Capital Rolls Out Global Investor Protection Program This Quarter

Zurich, Switzerland, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Crown Point Capital has officially announced the launch of its Global Investor Protection Program,…

7 months ago

Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum

Expenses significantly lower with expansion on multiple efforts; Q2 2025 loss from operations reduced to $5.4 million vs $8.6 million…

7 months ago

Foresight Reports Second Quarter 2025 andFirst Half 2025 Financial Results

NESS ZIONA, Israel, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the…

7 months ago

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

    - Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial - Expanded global IP protection by securing…

7 months ago

UGRO CAPITAL ANNOUNCES FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2025

Reports AUM of INR 12,081 Cr, up 31% (YoY); Total Income of INR 421.8 Cr, up 40% (YoY); and PAT…

7 months ago